Index RUT
P/E 13.58
EPS (ttm) 4.64
Insider Own 2.37%
Shs Outstand 69.86M
Perf Week 4.68%
Market Cap 4.32B
Forward P/E 9.46
EPS next Y 6.67
Insider Trans -
Shs Float 66.92M
Perf Month 7.41%
Income 326.66M
PEG 0.36
EPS next Q 1.54
Inst Own 102.29%
Short Float 7.06%
Perf Quarter 14.94%
Sales 1.30B
P/S 3.33
EPS this Y 5.55%
Inst Trans -1.01%
Short Ratio 4.74
Perf Half Y -8.87%
Book/sh 11.68
P/B 5.40
EPS next Y 1.37%
ROA 21.98%
Short Interest 4.72M
Perf Year -29.62%
Cash/sh 10.41
P/C 6.06
EPS next 5Y 37.73%
ROE 51.73%
52W Range 50.20 - 100.85
Perf YTD 1.73%
Dividend Est. -
P/FCF 16.71
EPS past 5Y 35.30%
ROI 22.81%
52W High -37.46%
Beta 0.53
Dividend TTM -
Quick Ratio 5.45
Sales past 5Y 36.54%
Gross Margin 65.38%
52W Low 25.64%
ATR (14) 2.07
Dividend Ex-Date -
Current Ratio 5.80
EPS Y/Y TTM 1065.78%
Oper. Margin 38.06%
RSI (14) 58.39
Volatility 3.85% 3.08%
Employees 834
Debt/Eq 0.76
Sales Y/Y TTM 38.65%
Profit Margin 25.20%
Recom 1.18
Target Price 97.50
Option/Short Yes / Yes
LT Debt/Eq 0.76
EPS Q/Q 184.77%
Payout 0.00%
Rel Volume 0.65
Prev Close 63.81
Sales Surprise 4.25%
EPS Surprise 22.29%
Sales Q/Q 34.52%
Earnings May 02 BMO
Avg Volume 995.75K
Price 63.07
SMA20 4.23%
SMA50 3.99%
SMA200 -4.52%
Trades
Volume 651,608
Change -1.16%
Date
Action
Analyst
Rating Change
Price Target Change
Dec-18-23 Downgrade
William Blair
Outperform → Mkt Perform
Dec-04-23 Initiated
TD Cowen
Outperform
$100
Sep-29-23 Initiated
William Blair
Outperform
Mar-08-23 Initiated
JMP Securities
Mkt Outperform
$120
Nov-30-22 Initiated
SVB Leerink
Outperform
Oct-13-22 Initiated
Mizuho
Buy
$105
May-09-22 Initiated
B. Riley Securities
Buy
$91
Apr-13-22 Initiated
Truist
Buy
$77
Feb-01-21 Initiated
SVB Leerink
Outperform
$24
Jun-29-20 Resumed
Jefferies
Buy
$29
Aug-16-19 Upgrade
CJS Securities
Market Perform → Market Outperform
Nov-02-17 Upgrade
Wells Fargo
Market Perform → Outperform
Nov-08-16 Reiterated
RBC Capital Mkts
Outperform
$6 → $12
Sep-23-16 Resumed
Credit Suisse
Neutral
Feb-24-16 Reiterated
RBC Capital Mkts
Outperform
$9 → $6
Dec-11-15 Downgrade
Credit Suisse
Outperform → Neutral
Sep-30-15 Downgrade
Wells Fargo
Outperform → Market Perform
Jul-20-15 Initiated
Wells Fargo
Outperform
Jul-20-15 Initiated
Robert W. Baird
Outperform
$10
Jul-20-15 Initiated
RBC Capital Mkts
Outperform
$10
Show Previous Ratings
Apr-19-24 12:10PM
Apr-18-24 08:00AM
Apr-15-24 06:00PM
09:50AM
Apr-13-24 12:12PM
09:00AM
Loading…
Apr-11-24 09:00AM
Apr-10-24 02:18PM
Apr-09-24 06:00PM
Apr-05-24 09:00AM
Apr-03-24 05:45PM
Mar-28-24 10:04AM
07:30AM
Mar-26-24 05:45PM
Mar-25-24 09:00AM
Mar-22-24 09:30AM
05:45PM
Loading…
Mar-20-24 05:45PM
Mar-14-24 05:45PM
09:50AM
Mar-13-24 04:30PM
Mar-12-24 09:00AM
Mar-11-24 07:01PM
Mar-08-24 05:45PM
03:00AM
Mar-07-24 09:40AM
Mar-06-24 09:55AM
09:30AM
Mar-05-24 10:15AM
08:30AM
08:00AM
Mar-04-24 08:30AM
08:30AM
Loading…
Feb-28-24 08:30AM
Feb-27-24 09:00AM
Feb-26-24 11:00AM
08:30AM
Feb-23-24 11:00AM
10:48AM
09:30AM
Feb-22-24 09:30AM
08:30AM
08:12AM
07:33AM
(Associated Press Finance)
07:00AM
03:55AM
Feb-19-24 09:55AM
09:30AM
08:30AM
Feb-16-24 05:45PM
Feb-15-24 10:00AM
Feb-13-24 01:36PM
08:30AM
Feb-08-24 05:45PM
08:00AM
Feb-06-24 09:00AM
Feb-02-24 05:45PM
Jan-26-24 05:45PM
Jan-23-24 12:10PM
09:00AM
07:45AM
Jan-18-24 05:45PM
Jan-12-24 05:45PM
09:37AM
09:23AM
Jan-11-24 08:00AM
Jan-10-24 09:00AM
Jan-09-24 08:00AM
08:00AM
07:55AM
Jan-08-24 09:51AM
Jan-05-24 05:45PM
Jan-03-24 08:30AM
Jan-01-24 12:52PM
09:30AM
Dec-29-23 05:45PM
09:00AM
Dec-27-23 06:41PM
Dec-20-23 08:00AM
Dec-18-23 07:30AM
Dec-15-23 09:30AM
Dec-12-23 09:00AM
Dec-11-23 09:35AM
Nov-29-23 09:00AM
Nov-17-23 09:00AM
Nov-08-23 08:00AM
Nov-06-23 09:00AM
Nov-04-23 12:53PM
Nov-02-23 09:30AM
09:16AM
07:38AM
(Associated Press Finance)
07:00AM
Nov-01-23 11:59AM
Oct-30-23 03:39PM
Oct-26-23 05:45PM
10:02AM
07:52AM
Oct-25-23 09:30AM
Oct-19-23 05:45PM
09:00AM
08:00AM
Oct-09-23 09:30AM
01:51AM
Lantheus Holdings, Inc. engages in the provision of diagnostic imaging and nuclear medicine products. The firm develops products that help healthcare professionals in patient management and outcomes and assists clinicians with the detection of cardiovascular disease. It operates through the U.S. and International geographical segments. The U.S. segment produces and markets products, radiopharmacies, PMFs, integrated delivery networks, hospitals, clinics, and group practices throughout the United States. The International segment offers direct distribution in Canada and third-party distribution relationships in Europe, Canada, Australia, Asia-Pacific, Central America, and South America. The company was founded in 1956 and is headquartered in Bedford, MA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Sabens Andrea Chief Accounting Officer Apr 15 '24 Sale 61.24 341 20,883 63,239 Apr 17 04:30 PM Marshall Robert J. Jr. CFO and Treasurer Mar 15 '24 Sale 60.00 20,000 1,200,000 113,749 Mar 19 04:30 PM Sabens Andrea Chief Accounting Officer Mar 13 '24 Sale 60.48 341 20,624 63,204 Mar 15 04:30 PM Blanchfield Paul President Mar 07 '24 Sale 61.96 18,023 1,116,705 103,357 Mar 11 04:30 PM LENO SAM R Director Mar 06 '24 Option Exercise 16.30 2,045 33,334 59,982 Mar 07 04:30 PM Lantheus Alpha Therapy, LLC 10% Owner Mar 06 '24 Buy 0.95 60,431,039 57,409,487 116,773,394 Mar 08 11:24 AM LENO SAM R Director Mar 06 '24 Sale 63.50 2,045 129,857 57,937 Mar 07 04:30 PM LENO SAM R Director Mar 05 '24 Option Exercise 16.30 2,045 33,334 59,982 Mar 07 04:30 PM LENO SAM R Director Mar 05 '24 Sale 64.62 2,045 132,148 57,937 Mar 07 04:30 PM LENO SAM R Director Mar 04 '24 Option Exercise 19.85 22,389 444,499 80,326 Mar 06 05:15 PM Heino Mary Anne Director Mar 04 '24 Sale 65.31 93,863 6,129,889 251,643 Mar 05 08:28 PM LENO SAM R Director Mar 04 '24 Sale 65.42 22,389 1,464,749 57,937 Mar 06 05:15 PM Sabens Andrea Chief Accounting Officer Feb 13 '24 Sale 55.31 341 18,861 58,403 Feb 15 04:30 PM Sabens Andrea Chief Accounting Officer Jan 16 '24 Sale 56.01 341 19,099 58,744 Jan 18 04:30 PM Marshall Robert J. Jr. CFO and Treasurer Dec 15 '23 Sale 78.24 10,000 782,400 103,170 Dec 19 05:00 PM Sabens Andrea Chief Accounting Officer Dec 13 '23 Sale 75.62 341 25,786 59,085 Dec 15 04:30 PM Blanchfield Paul President Nov 16 '23 Sale 67.96 1,500 101,940 88,651 Nov 20 04:30 PM Heino Mary Anne CEO Nov 13 '23 Sale 63.72 11,780 750,611 317,687 Nov 15 04:32 PM Sabens Andrea Chief Accounting Officer Nov 13 '23 Sale 63.57 341 21,677 59,426 Nov 15 04:30 PM Niedzwiecki Daniel See Remarks Sep 15 '23 Option Exercise 17.79 2,846 50,630 69,141 Sep 19 04:30 PM Niedzwiecki Daniel See Remarks Sep 15 '23 Sale 66.43 2,846 189,060 66,295 Sep 19 04:30 PM Blanchfield Paul President Aug 21 '23 Sale 66.10 408 26,969 90,067 Aug 23 04:30 PM Blanchfield Paul President Aug 18 '23 Sale 65.19 1,500 97,785 90,475 Aug 22 04:30 PM Marshall Robert J. Jr. CFO and Treasurer Aug 15 '23 Sale 68.52 10,000 685,200 108,298 Aug 17 04:30 PM Heino Mary Anne CEO Aug 11 '23 Sale 68.58 10,950 750,981 329,467 Aug 15 05:35 PM Niedzwiecki Daniel See Remarks Aug 11 '23 Sale 67.93 4,297 291,895 66,295 Aug 15 04:54 PM Sabens Andrea Chief Accounting Officer Jul 19 '23 Sale 90.87 1,752 159,209 59,767 Jul 21 04:30 PM Baylor-Henry Minnie Director Jun 02 '23 Sale 86.22 6 517 16 Oct 13 05:03 PM Blanchfield Paul President May 18 '23 Sale 97.93 1,500 146,895 92,743 May 22 06:47 PM Marshall Robert J. Jr. CFO and Treasurer May 15 '23 Sale 99.36 10,000 993,600 118,298 May 17 04:30 PM Sabens Andrea Chief Accounting Officer May 15 '23 Sale 99.36 385 38,254 61,519 May 17 04:31 PM Niedzwiecki Daniel See Remarks May 11 '23 Sale 98.82 6,113 604,087 72,058 May 15 06:34 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite